GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Alivus Life Sciences Ltd
Alivus Life Sciences Board Meeting to Approve Q2 FY27 Financial Results
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 21 Oct 2026, 05:09 PM IST  ·  BSE ID: 8977babe-eadc-4b78-a32e-4e8da580acef
View Original BSE Filing (PDF)
💡
In Simple Terms
Alivus Life Sciences will hold a board meeting on October 29, 2026, to approve its financial results for Q2 FY27.
🤖 AI Summary
  • Alivus Life Sciences Ltd. Board Meeting scheduled for Thursday, October 29, 2026.
  • The meeting will consider and approve Unaudited Financial Results for Q2 FY27.
  • Results cover the quarter and half year ended September 30, 2026.
  • Trading window for designated persons closed from October 1, 2026 to October 31, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this announcement.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results, which will provide an update on the company's performance for the quarter and half year ended September 30, 2026.
🔍
Management Signal
The announcement indicates management's adherence to regulatory requirements for disclosing upcoming board meetings and financial reporting timelines.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
October 29, 2026 — Board Meeting for Q2 FY27 results approval.
Release of Unaudited Financial Results for quarter and half year ended September 30, 2026.
Trading window reopening post-October 31, 2026.
LOW RISK This is a routine regulatory announcement for an upcoming board meeting, not an event that introduces new risks.
💡 Investor Takeaway
Alivus Life Sciences Ltd. has scheduled a Board Meeting for October 29, 2026, to approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026. The trading window remains closed for designated persons until October 31, 2026.
📅 Company Track Record
Alivus Life Sciences Ltd. reported a Profit for Year of Rs. 5,644.83 Million for FY26, an increase of 16.24% YoY. The company also declared a dividend of Rs. 5/- per share for FY26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the Board Meeting for Alivus Life Sciences Ltd. scheduled?
The Board Meeting for Alivus Life Sciences Ltd. is scheduled for Thursday, October 29, 2026.
What financial results will be considered at the upcoming Board Meeting?
The Board Meeting will consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.
When is the trading window closed for Alivus Life Sciences Ltd.?
The trading window for designated persons of Alivus Life Sciences Ltd. is closed from October 1, 2026, to October 31, 2026 (both days inclusive).

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.